{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:27Z","timestamp":1790794167883,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.waojou.2019.100078","type":"journal-article","created":{"date-parts":[[2019,12,8]],"date-time":"2019-12-08T23:30:58Z","timestamp":1575847858000},"page":"100078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction"],"prefix":"10.1016","volume":"12","author":[{"given":"Silvana","family":"Cianchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bradicich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Dente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Celi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2019.100078_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2005.06.011","article-title":"Differences in airway remodelling between subjects with severe and moderate asthma","volume":"116","author":"Pepe","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2009.03.049","article-title":"Airway remodelling in subjects with severe asthma with or without chronic persistent airflow obstruction","volume":"124","author":"Kaminska","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.164.5.2011026","article-title":"Factors associated with persistent airflow limitation in severe asthma","volume":"164","author":"ten Brinke","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.waojou.2019.100078_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.04.00077803","article-title":"Parameters associated with persistent airflow obstruction in chronic severe asthma","volume":"24","author":"Bumbacea","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib5","first-page":"202","article-title":"Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findings","volume":"18","author":"Yamaguchi","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.rmed.2014.08.008","article-title":"Transforming growth factor \u03b2 and severe asthma: a perfect storm","volume":"108","author":"Al-Alawi","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.waojou.2019.100078_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/all.13323","article-title":"Airway pathology in severe asthma is related to airflow obstruction but not symptom control","volume":"73","author":"Ferreira","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2019.100078_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Bronchoscopic exploratory research study of biomarkers in corticosteroid-refractory asthma (BOBCAT) study group. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/all.12580","article-title":"Sputum periostin in patients with different severe asthma phenotypes","volume":"70","author":"Bobolea","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2019.100078_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1183\/13993003.01384-2015","article-title":"Serum periostin in obstructive airways disease","volume":"47","author":"Fingleton","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaci.2013.04.050","article-title":"Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids","volume":"132","author":"Kanemitsu","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/02770903.2013.860164","article-title":"Fibroblast growth factor-2 is a sputum remodelling biomarker of severe asthma","volume":"51","author":"\u00c9Y","year":"2014","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.waojou.2019.100078_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1165\/rcmb.2014-0184OC","article-title":"Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin","volume":"52","author":"Guzy","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.waojou.2019.100078_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3858\/emm.2011.43.4.018","article-title":"Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-\u03b3","volume":"43","author":"Lee","year":"2011","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.waojou.2019.100078_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1165\/rcmb.2012-0151OC","article-title":"Transforming growth factor-\u03b2-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2","volume":"48","author":"Schuliga","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.waojou.2019.100078_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.1201827","article-title":"YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-\u03baB pathways, causing bronchial smooth muscle proliferation and migration","volume":"190","author":"Tang","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib17","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma","volume":"160","author":"Jatakanon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.waojou.2019.100078_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/09031936.00120714","article-title":"European respiratory society\/American thoracic society severe asthma international guidelines Task Force. From the authors: international european respiratory society\/American thoracic society guidelines on severe asthma","volume":"44","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib19","series-title":"Global strategy for asthma management and prevention","author":"Gina Global Initiative for Asthma","year":"2017"},{"key":"10.1016\/j.waojou.2019.100078_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1183\/09031936.98.11061354","article-title":"References values for forced spirometry. Group of the european community respiratory health survey","volume":"11","author":"Roca","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.05.00034505","article-title":"General considerations for lung function testing","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2019.100078_bib23","first-page":"3s","article-title":"Sputum induction","volume":"37","author":"Paggiaro","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.waojou.2019.100078_bib24","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1365-2222.2007.02850.x","article-title":"Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonarydisease patients? Comparison with isotonic saline","volume":"37","author":"Cianchetti","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2019.100078_bib25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","article-title":"National heart, lung, and blood institute severe asthma research Program.Analyses of asthma severity phenotypes and inflammatory proteins in subjectsstratified by sputum granulocytes","volume":"125","author":"Hastie","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.waojou.2019.100078_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","article-title":"Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals","volume":"118","author":"Takayama","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib28","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1007\/s00018-017-2649-z","article-title":"The role of periostin in lung fibrosis and airway remodelling","volume":"74","author":"O'Dwyer","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.waojou.2019.100078_bib29","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.1009426107","article-title":"Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma","volume":"107","author":"Sidhu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl l","key":"10.1016\/j.waojou.2019.100078_bib30","article-title":"Airway remodelling in asthma","volume":"123","author":"Vignola","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.waojou.2019.100078_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mai.2001.111928","article-title":"Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis","volume":"107","author":"Hoshino","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2006.12.653","article-title":"Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge","volume":"119","author":"Jeon","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100078_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-016-0230-4","article-title":"Periostin levels and eosinophilic inflammation in poorly-controlled asthma","volume":"16","author":"Simpson","year":"2016","journal-title":"BMC Pulm Med"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119312347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119312347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:41:15Z","timestamp":1761849675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119312347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1939455119312347"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100078","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100078"}}